Paper31444481
Protozoan persister-like cells and drug treatment failure.
Barrett MP and 4 others. Nat Rev Microbiol, 2019. Cited by 119 papers, by iCite.
Cite this record
ConductScience Library. Protozoan persister-like cells and drug treatment failure. Papers, record 31444481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31444481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiprotozoal Agents | Major topic |
| Drug Tolerance | Major topic |
| Leishmania | Major topic |
| Plasmodium | Major topic |
| Toxoplasma | Major topic |
| Trypanosoma cruzi | Major topic |
| Biological Variation, Population | |
| Chagas Disease | |
| Humans | |
| Leishmaniasis | |
| Malaria | |
| Toxoplasmosis | |
| Treatment Failure |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI143857 | NIAID NIH HHS | United States | R01AI143857 | PubMed | NIH RePORTER |
| R01 AI164473 | NIAID NIH HHS | United States | R01AI164473 | PubMed | NIH RePORTER |
| MR/S019650/1 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| R21 AI144591 | NIAID NIH HHS | United States | R21AI144591 | PubMed and NIH | NIH RePORTER |
| MR/L018853/1 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| R21 AI109530 | NIAID NIH HHS | United States | R21AI109530 | PubMed and NIH | NIH RePORTER |
| R01 AI118426 | NIAID NIH HHS | United States | R01AI118426 | PubMed and NIH | NIH RePORTER |
| R01 AI034036 | NIAID NIH HHS | United States | R01AI034036 | PubMed and NIH | NIH RePORTER |
| Wellcome Trust | United Kingdom | PubMed | PubMed | ||
| R01AI124692 | NIH | NIH RePORTER |
References152
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29743474 | A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum. | Nat Commun | 2018 | https://conductscience.org/library/papers/29743474 | PubMed |
| 2 | 25502314 | Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. | Science | 2015 | https://conductscience.org/library/papers/25502314 | PubMed |
| 3 | 29241041 | Inhibiting the Plasmodium eIF2α Kinase PK4 Prevents Artemisinin-Induced Latency. | Cell Host Microbe | 2017 | https://conductscience.org/library/papers/29241041 | PubMed |
| 4 | 20133198 | Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. | Trends Parasitol | 2010 | https://conductscience.org/library/papers/20133198 | PubMed |
| 5 | 8542997 | Plasmodium falciparum: recrudescence of parasites in culture. | Exp Parasitol | 1995 | https://conductscience.org/library/papers/8542997 | PubMed |
| 6 | 29602951 | A latent ability to persist: differentiation in Toxoplasma gondii. | Cell Mol Life Sci | 2018 | https://conductscience.org/library/papers/29602951 | PubMed |
| 7 | 23768488 | Microbial persistence and the road to drug resistance. | Cell Host Microbe | 2013 | https://conductscience.org/library/papers/23768488 | PubMed |
| 8 | 11897575 | Malaria parasites giving rise to recrudescence in vitro. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11897575 | PubMed |
| 9 | 28831944 | Biological factors that impinge on Chagas disease drug development. | Parasitology | 2017 | https://conductscience.org/library/papers/28831944 | PubMed |
| 10 | 28673423 | Chagas disease. | Lancet | 2018 | https://conductscience.org/library/papers/28673423 | PubMed |
| 11 | 21126543 | The Apicomplexan AP2 family: integral factors regulating Plasmodium development. | Mol Biochem Parasitol | 2011 | https://conductscience.org/library/papers/21126543 | PubMed |
| 12 | 24438211 | Toxoplasma development - turn the switch on or off? | Cell Microbiol | 2014 | https://conductscience.org/library/papers/24438211 | PubMed |
| 13 | 19064625 | Evidence of artemisinin-resistant malaria in western Cambodia. | N Engl J Med | 2008 | https://conductscience.org/library/papers/19064625 | PubMed |
| 14 | 24572359 | A cascade of DNA-binding proteins for sexual commitment and development in Plasmodium. | Nature | 2014 | https://conductscience.org/library/papers/24572359 | PubMed |
| 15 | 8397917 | Toxoplasmosis in the non-AIDS immunocompromised host. | Curr Clin Top Infect Dis | 1993 | https://conductscience.org/library/papers/8397917 | PubMed |
| 16 | 26350965 | Novel Approaches Reveal that Toxoplasma gondii Bradyzoites within Tissue Cysts Are Dynamic and Replicating Entities In Vivo. | mBio | 2015 | https://conductscience.org/library/papers/26350965 | PubMed |
| 17 | 29578409 | Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure. | Elife | 2018 | https://conductscience.org/library/papers/29578409 | PubMed |
| 18 | 26694030 | Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. | Nat Commun | 2015 | https://conductscience.org/library/papers/26694030 | PubMed |
| 19 | 20160056 | Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20160056 | PubMed |
| 20 | 30001347 | Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery. | PLoS Negl Trop Dis | 2018 | https://conductscience.org/library/papers/30001347 | PubMed |
Cited by89
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42973691 | Complex I inhibition collapses host bioenergetics and activates p53-dependent apoptosis in Theileria annulata infected cells. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42973691 | PubMed |
| 42832560 | Active transcriptome remodeling underlies antimony-induced drug tolerance in persister-like Leishmania parasites. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42832560 | PubMed |
| 42625565 | NN-assisted image analysis for quantifying intracellular Trypanosoma cruzi infection. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42625565 | PubMed |
| 42603444 | Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay. | Int J Parasitol Drugs Drug Resist | 2026 | https://conductscience.org/library/papers/42603444 | PubMed |
| 42340977 | Beyond resistance: Emerging methods to dissect drug responses in Leishmania. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42340977 | PubMed |
| 42286211 | Multi-drug tolerance in Leishmania persister-like cells. | Commun Biol | 2026 | https://conductscience.org/library/papers/42286211 | PubMed |
| 42221541 | Trypanosomatid parasites, translational research in a One Health, One World environment. | Front Chem | 2026 | https://conductscience.org/library/papers/42221541 | PubMed |
| 42213660 | Leishmania major virulence attenuation in vitro: An old conundrum revisited in the omics era. | PLoS Negl Trop Dis | 2026 | https://conductscience.org/library/papers/42213660 | PubMed |
| 42185256 | Trypanosoma cruzi cell atlas as a single-cell resource for understanding parasite population heterogeneity and differentiation. | Nat Commun | 2026 | https://conductscience.org/library/papers/42185256 | PubMed |
| 42129552 | SNOR promotes translation restart after dormancy. | Nature | 2026 | https://conductscience.org/library/papers/42129552 | PubMed |
| 42108536 | A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate. | J Antimicrob Chemother | 2026 | https://conductscience.org/library/papers/42108536 | PubMed |
| 41929147 | A Novel Eukaryotic Ribosome Factor Enables Translation Restart Following Cellular Dormancy. | bioRxiv | 2026 | https://conductscience.org/library/papers/41929147 | PubMed |
| 41915614 | In Vivo Trypanocidal Activity of the Drug Disulfiram Combined with Benznidazole. | ACS Infect Dis | 2026 | https://conductscience.org/library/papers/41915614 | PubMed |
| 41888558 | Nonlinear dynamics of Nosema ceranae and the fragile resilience of honeybee colonies under environmental strain. | Sci Rep | 2026 | https://conductscience.org/library/papers/41888558 | PubMed |
| 41839971 | Unravelling complex interactions during Toxoplasma, Plasmodium, and Leishmania co-infections in French Guiana. | Sci Rep | 2026 | https://conductscience.org/library/papers/41839971 | PubMed |
| 41676625 | High throughput quantitative tracking of Plasmodium falciparum clonal blood stage parasite growth and applications for antimalarial drug discovery. | bioRxiv | 2026 | https://conductscience.org/library/papers/41676625 | PubMed |
| 41557738 | Untargeted metabolomics for triaging of cytochrome b inhibitors during Chagas' disease drug discovery. | PLoS Negl Trop Dis | 2026 | https://conductscience.org/library/papers/41557738 | PubMed |
| 40906736 | BFD2 mediates inflammation, apoptosis, and pre-anxiety-like behaviors induced by acute Toxoplasma gondii infection. | PLoS Negl Trop Dis | 2025 | https://conductscience.org/library/papers/40906736 | PubMed |
| 40699059 | Beyond the first case of Chagas disease: the Berenice strain as a model for understanding long-term Trypanosoma cruzi infection. | Mem Inst Oswaldo Cruz | 2025 | https://conductscience.org/library/papers/40699059 | PubMed |
| 40482566 | The importance of persistence and dormancy in Trypanosoma cruzi infection and Chagas disease. | Curr Opin Microbiol | 2025 | https://conductscience.org/library/papers/40482566 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AQP1 | 358 | PubTator's text mining | https://conductscience.org/library/genes/358 | NCBI Gene |
| EIF2A | 83939 | PubTator's text mining | https://conductscience.org/library/genes/83939 | NCBI Gene |
| G6PD | 2539 | PubTator's text mining | https://conductscience.org/library/genes/2539 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31444481
GET https://conductscience.org/api/papers/v1/31444481/references?page=2